generic-drug-development-the-way-forward 
Express Pharma
APRIL 11, 2023
Even though the global generic drug market is growing at a CAGR of ~8 per cent, many Indian pharma companies are witnessing their profitability coming down continuously. The pundits are unanimous in their response – changes in the US generic drug market. What to do? Neither of these is easy.
Express Pharma
MARCH 21, 2024
vriddhi 2024, Indian Drug Manufacturers’ Association (IDMA) 62nd Annual day celebrations, was organised on February 23-24, 2024 at FLAME University, the philanthropic venture of ENAM holdings in Pune, in partnership with Bain & Company.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
AUGUST 12, 2022
In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. This won’t be the first time an AdCom will convene to deliberate the drug’s approval chances.
pharmaphorum
SEPTEMBER 1, 2022
Massoumi says Dr. B allows patients to receive the drugs promptly, without an in-person office visit, and, at times, at no cost. “We “We are currently focused on offering a convenient way to get prescriptions. “We are currently focused on offering a convenient way to get prescriptions. The platform.
pharmaphorum
OCTOBER 16, 2020
The repurposing of drugs is becoming more common, especially in the field of rare diseases. In the past, repurposing has mostly been driven by academics looking for new possibilities in generics. In the past, repurposing has mostly been driven by academics looking for new possibilities in generics.
Quality Matters
OCTOBER 13, 2021
This year’s theme is a “shared vision for a better world” to showcase how standards are essential to achieving the United Nations Sustainable Development Goals by accelerating access to clean water, quality healthcare, sanitation, decent housing, clean energy and more. In fact, quality standards are a big reason why we in the U.S.
FDA Law Blog: Biosimilars
JUNE 8, 2023
The pandemic had changed the way people live, work and communicate. By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — On May 11, 2023, the U.S. Department of Health and Human Services declared the long-awaited end of the federal COVID-19 Public Health Emergency. Such changes are not limited to personal circumstances.
Expert insights. Personalized for you.
92 
Let's personalize your content